Effect of high versus low dose of human recombinant erythropoietin on the Anemia of prematurity
Phase 2
- Conditions
- anemia of prematurity.Anaemia of prematurity
- Registration Number
- IRCT138711201162N13
- Lead Sponsor
- Mashhad university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Gestational age less than 34 weeks, breast milk feeding, hematocrit <30% when infant age is between 2 to 3 weeks or HCT<25% when infant age is more than 3 weeks. Exclusion criteria: Infants with hemolytic anemia, active bleeding or congenital malformation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemotocrite and reticulocyte count. Timepoint: the beginning, third day and one week after the end of treatment. Method of measurement: venous sampling and laboratory measurement.
- Secondary Outcome Measures
Name Time Method